Dr David Fernandez-Antoran

University of Cambridge

University departments
Wellcome Trust CRUK Gurdon Institute
University institutes
Wellcome Trust CRUK Gurdon Institute

Position: Group Leader
Personal home page:

PubMed journal articles - click here

Dr David Fernandez-Antoran is pleased to consider applications from prospective PhD students.

Research description

We use long-term human and mouse 3D primary epithelial cultures, in vivo cell lineage tracing, mathematical modelling, next generation sequencing methods and state-of-the-art confocal microscopy techniques to unravel the molecular responses and the cellular interactions that control normal and mutant cell behaviours after exposure to different doses of ionising radiation.

The final aim of our research is to understand the effects of ionising radiation in tumours and normal tissues and set the basis for designing external interventions that can modulate cell competition outcomes, eliminate oncogenic mutations from tissues and reduce the risk of cancer initiation and progression.

Research Programme or Virtual Institute
Not applicable
Secondary Programme
Not applicable
Strategic Resources
CRUK RadNet Cambridge
Methods and technologies
Cell culture
Computational modelling
Confocal microscopy
DNA sequencing
Fluorescence microscopy
Gene expression profiling
In vivo modelling
Model organisms
Tumour type interests
Recent publications:
 Retrieving latest data from feed...

Symplectic Elements feed provided by Research Information, University of Cambridge

Key publications
  • Colom et al. Mutant clones in normal epithelium outcompete and eliminate emerging tumours. Nature 598, 510–514 (2021). https://doi.org/10.1038/s41586-021-03965-7
  • Fowler et al. Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site. 
  • Piedrafita et al (2020) A single-progenitor model as the unifying paradigm of epidermal and esophageal epithelial maintenance in mice. Nature Communications doi.org/10.1038/s41467-020-15258-0
  • Fernandez-Antoran et al (2019) Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell doi.org/10.1016/j.stem.2019.06.011